ABCL

#2371
AbCellera Biologics Inc. Common Shares
3.76 USD
+2.73%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
3.76
3.76
Intervallo Annuale
1.94
6.52
Variazione giornaliera
+2.73%
Variazione Mensile
+6.52%
Variazione di 6 mesi
-33.69%
Variazione Annuale
+55.37%
Chiusura Precedente
3.66
Apertura
3.76
Bid
Ask
Minimo
3.76
High
3.76
Volume
45
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore 20212022202320242025 TTM

AbCellera Biologics Inc

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Notizie